Table 1. Participant Sociodemographic Characteristics.
| Variable | VRE-DCS (n=13) | VRE-placebo (n=12) | Test of significance |
|---|---|---|---|
| Age M (SD) | 47.77 (11.92) | 43.75 (8.72) | t=−0.96, p=0.350 |
| Gender | |||
| Male | 8 | 11 | χ2=3.11, p=0.078 |
| Female | 5 | 1 | |
| Education | |||
| Some or no high school | 0 | 0 | χ2=2.00, p=0.573 |
| High school | 2 | 1 | |
| Some college | 3 | 2 | |
| College | 8 | 9 | |
| Marital status | |||
| Cohabitating | 1 | 2 | χ2=2.63, p=0.452 |
| Separated/divorced | 4 | 1 | |
| Married | 5 | 7 | |
| Single | 3 | 2 | |
| Ethnicity | |||
| Caucasian | 10 | 11 | χ2=1.34, p=0.511 |
| Black | 1 | 0 | |
| Hispanic | 2 | 1 | |
| Major depression | 9 | 7 | χ2=0.32, p=0.571 |
| Trauma history | 13 | 9 | χ2=3.69, p=0.055 |
| Concurrent medication usea | 9 | 5 | χ2=1.92, p=0.165 |
| VR sessions completed | 11.00 (1.00) | 9.33 (3.34) | t=−1.62, p=0.121 |
a
VRE-DCS: eight antidepressants, four other psychiatric medications, four both; VRE-placebo: four antidepressants, five other psychiatric medications, four both.